ACADIA PHARMACEUTICALS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.12 USD | +1.72% |
|
-11.35% | -51.50% |
| 05-10 | UBS Cuts Price Target on ACADIA Pharmaceuticals to $25 From $27, Keeps Buy Rating | MT |
| 05-10 | Oppenheimer Adjusts ACADIA Pharmaceuticals Price Target to $17 From $19, Maintains Perform Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Other Biotechnology & Medical Research | +2.22% | -11.35% | -51.50% | -31.35% | -41.46% | 2.46B |  | | |
- Stock Market
- Equities
- ACAD Stock
- Charts ACADIA Pharmaceuticals Inc.
- Relative Strength Chart